ARTICLE | Management Tracks
Plus: CRISPR’s CMO to depart and a new CFO for Alterity
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
December 23, 2023 1:20 AM UTC
Pacira BioSciences Inc. (NASDAQ:PCRX) named Frank Lee CEO and a director and Paul Hastings chair, both effective Jan. 2 — the day after Chairman and CEO David Stack is set to retire. Lee was CEO and member of the board of Forma Therapeutics Inc.; Hastings, who joined Pacira’s board in 2011, is CEO of Nkarta Inc. (NASDAQ:NKTX).
CRISPR Therapeutics AG (NASDAQ:CRSP) disclosed in an SEC filing the departure of CMO Phuong Khanh Morrow, effective Jan. 26. Morrow joined CRISPR in May 2022. The departure comes days after FDA approved the company’s Casgevy exagamglogene autotemcel, the first CRISPR-based gene editing therapy. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/651025/pacira-names-lee-ceo-hastings-chair